0001104659-24-010827.txt : 20240205 0001104659-24-010827.hdr.sgml : 20240205 20240205212432 ACCESSION NUMBER: 0001104659-24-010827 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240202 FILED AS OF DATE: 20240205 DATE AS OF CHANGE: 20240205 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ashar Bhavesh CENTRAL INDEX KEY: 0001849740 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39044 FILM NUMBER: 24597848 MAIL ADDRESS: STREET 1: C/O SPRINGWORKS THERAPEUTICS STREET 2: 100 WASHINGTON BLVD CITY: STAMFORD STATE: CT ZIP: 05902 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SpringWorks Therapeutics, Inc. CENTRAL INDEX KEY: 0001773427 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 WASHINGTON BOULEVARD CITY: STAMFORD STATE: CT ZIP: 06902 BUSINESS PHONE: 203-883-9490 MAIL ADDRESS: STREET 1: 100 WASHINGTON BOULEVARD CITY: STAMFORD STATE: CT ZIP: 06902 4 1 tm245274-2_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2024-02-02 0 0001773427 SpringWorks Therapeutics, Inc. SWTX 0001849740 Ashar Bhavesh C/O SPRINGWORKS THERAPEUTICS, INC. 100 WASHINGTON BLVD. STAMFORD CT 06902 0 1 0 0 Chief Commercial Officer 0 Common Stock 2024-02-02 4 S 0 1089 43.7465 D 65121 D Common Stock 2024-02-02 4 S 0 1667 44.3119 D 63454 D Common Stock 2024-02-02 4 S 0 378 45.9979 D 63076 D Common Stock 2024-02-02 4 S 0 88 46.3733 D 62988 D Common Stock 2024-02-05 4 S 0 4834 49.3245 D 58154 D The sales reported on this Form 4 were effected pursuant to a trading plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, adopted on December 16, 2022. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.05 to $44.035. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.05 to $44.77. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.29 to $46.28. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.29 to $47.11. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.00 to $49.71. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. /s/ Francis I. Perier, Jr. as Attorney-in Fact 2024-02-05